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Objectives: To quantify and associate the levels of Th1 pro-inflammatory and Th2 anti-
inflammatory cytokines with the anthropometric measurements at the beginning of 
pregnancy. Methods: This prospective clinical and descriptive study included pregnant 
women 18 years of age and older. Serum levels of IL-4, IL-6, IL-10, IFN-γ, and TNF-α 
were measured by ELISA. Correlations were determined among the cytokines and 
anthropometric variables. Results: From 83 pregnant women IL-4 was significantly higher 
in Underweight compared to Overweight patients (97.5 ± 3.5 vs. 66.4 ± 17.6 pg/mL, p = .037), 
Underweight compared to Obesity Class I patients (97.5 ± 3.5 vs. 60.6 ± 17.2 pg/mL, p = .024) 
and in Normal Weight compared to Obesity Class I patients (72.2 ± 17.7 vs. 60.6 ± 17.2 pg/
mL, p = .026). TNF-α was significantly higher in Normal Weight compared to Obesity Class II 
patients (41.9 ± 26 vs. 24.9 ± 19.7 pg/mL, p = .031). IL-4 was positively correlated with TNF-α 
(r2 = .309, p = .005) and negatively correlated with pre-gestational BMI (r2 = -.243, p = .029). 
IL-10 was positively correlated with IL-4 (r2 = .356, p = .001) and TNF-α (r2 = .308, p = .005). 
Finally, IFN-γ was negatively correlated with IL-4 (r2 = -.246, p = .025), IL-6 (r2 = -.232, p = 
.035) and TNF-α (r2 = -.289, p = .008). Conclusion: In Mexican women, there is a low anti-
inflammatory cytokine profile at the beginning of pregnancy.
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Introduction
Obesity is recognized as a global health problem, being of 
particular interest before and during pregnancy due to its 
association with increased maternal and neonatal mortality 
and morbidity. In particular, obesity has been shown to induce 
metabolic disorders on both, the mother and the baby, even 
causing a possible transgenerational amplification of the 
prevalence of obesity, besides the well-known increased 
incidences of fetal death, macrosomia, shoulder dystocia, and 
childhood obesity. Even more, obesity in pregnancy has harmful 
effects on maternal health by increasing the risk of pregnancy-
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induced hypertension, gestational diabetes, and thromboembolic 
disease as well as increasing the risk of miscarriage1,2.
Among the proposed mechanisms by which obesity increases 
obstetric complications have been described the induction of 
oxidative stress, and changes in the balance of T helper (Th) 
lymphocyte subsets3,4. In line with this, the immune system, in 
general, can be divided into the innate and adaptive immune 
system. The first is a non-specific system that provides immediate 
defense against pathogens, while the second is more specific, 
characterized by T and B lymphocytes. B lymphocytes provide 
humoral immunity utilizing antibodies, whereas T cells provide 
mainly immunity mediated by cells5. Helper T cells (CD4+) can be 
grouped into different subsets of T CD4+ lymphocytes, termed T 
helper 1 (Th1) and T helper 2 (Th2) cells, characterized by their 
cytokine production profile. But besides this classical division, 
other subsets of helper T cells have been identified, including 
Th9, Th17, Th21, Th22, TFr and Treg6,7.
Th1 cells secrete pro-inflammatory cytokines such as 
interferon gamma (IFN-γ) and tumor necrosis factor alpha 
(TNF-α), while Th2 cells secrete anti-inflammatory cytokines 
such as interleukin (IL)-4, IL-10 and IL-138. IL-4 is the dominant 
factor for the promotion of growth and differentiation from 
Th0 to Th2, and directly inhibits the development of Th1 cells9. 
IFN-γ, on the other hand, indirectly promotes Th1 differentiation 
through overexpression of the IL-12 receptor, while inhibiting 
the growth of Th2 cells at the same time10. During healthy 
pregnancy, an increase in levels of IL-4, along with a decrease 
in IFN-γ have been shown. By contrast, an increase in Th1 has 
been demonstrated in cases of recurrent miscarriage  and in 
preeclampsia11-13.
One of the explanations that would associate obesity with 
immunological alterations during pregnancy is the fact that 
oxidized LDL (oxLDL) can exacerbate a chronic inflammatory 
microenvironment by stimulating the differentiation of naïve T 
CD4+ cells to Th1 cells, that predominately secrete IFN-γ14.
Until now, most of the studies describing the cytokines 
profile of pregnant women have focused on the pro-inflammatory 
profile, but there is not equivalent information related to the 
anti-inflammatory cytokines at the beginning of the gestation. 
We aimed to quantify and associate the levels of Th1 and 
Th2 cytokines, with the anthropometric measurements at the 
beginning of pregnancy and to clarify whether at the early stage 
of gestation in Mexican women a high pro-inflammatory or low 
anti-inflammatory profile predominates. If either is confirmed, 
this could add prognostic predictors to a population already 
known to be at high risk of obstetrical complications.
 
Materials and Methods 
Setting
This prospective clinical and descriptive study was carried out 
at the “Mónica Pretelini Sáenz” Maternal-Perinatal Hospital 
(HMPMPS), Health Institute of the State of Mexico (ISEM) during 
2017. The hospital is located in Toluca, Mexico, ~60 km west of 
Mexico City.
Patients
Pregnant women older than 18 years of age were invited to 
participate and written informed consent was obtained. Despite 
a large and growing immigration population, in this survey, 
we selected only Mexican women that have a characteristic 
miscegenation with elements from indigenous and European 
ancestry. Women with congenital heart disease, physically 
disabling conditions, infectious diseases, and autoimmune 
diseases were excluded and those who were lost to follow-up 
were not included in the final analysis.
Sample calculation
To ensure we obtained a representative sample of the pregnant 
women who received care at the clinic during 2017, the required 
sample size was calculated as follows:15.
Where N = annual population size at the clinic, e = the 
desired margin of error, z = z-score corresponding to the desired 
confidence interval, and p = percentage of the population with 
a given sampling result (p was unknown for our population, the 
worst scenario of 50% was chosen). Therefore, to obtain a 95% 
confidence interval for our population of 8500, a z-score of 1.96 
was chosen corresponding to a margin of error of 11%. This 
resulted in a required sample size of 79 patients. 
Physical exam
All pregnant women underwent a complete physical examination 
on each monthly medical appointment, including body weight, 
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height, body mass index (BMI), and blood pressure. Weight and 
height were measured using a calibrated adult scale (Seca, 
Hamburg, Germany). The blood pressure (BP; mmHg) was 
checked by auscultation using a standard sphygmomanometer 
(Riester Big Ben® Square; Jangingen, Germany). The patients 
were classified according to their BMI at each visit as follows: 
underweight < 18.5, normal weight 18.5 – 24.9, overweight 
25.0 – 29.9, class I obesity 30.0 – 34.9, class II obesity 35.0 – 
39.9, and class III obesity ≥ 40.0 and their BMI difference (BMI 
during first prenatal visit– pregestational BMI) was calculated 
using their recollection of their weight before their last menstrual 
period as their pregestational weight.
Nutritional & weight management
By protocol of the HMPMPS, all mothers who were overweight 
or obese were referred to the nutrition department, where they 
received personalized written nutritional guidance depending on 
their age, pre-pregnancy weight, current weight and BMI. Based 
on their daily caloric requirements, changes were made in their 
diet, appropriate to their caloric and nutritional needs.
Laboratorial analysis
After 8 hours of fasting, blood samples were drawn and routine 
analyses were performed for albumin (mg/dl), cholesterol (mg/
dl), creatinine (mg/dl), glucose (mg/dl), triglycerides (mg/dl), uric 
acid (mg/dl), liver profile (Dimension R × L Max, Dade Behring, 
USA), blood cytometry (Advia 120, Bayer Health) and urinalysis.
Quantification of cytokines
The serum levels of IL-10 (Invitrogen Cat. BMS215-2), IL-4 
(eBioscience catalog: BMS225/2), IL-6 (Enzo Cat. 80-0625), 
IFN-γ (Invitrogen Cat. BMS228) and TNF-α (Invitrogen Cat. 
BMS223-4) were measured by ELISA on an ELx800™ device 
(BioTek Instruments, Inc.) at the Research Laboratory of Ciprés 
Grupo Médico S.C. (CGM).
Statistical analysis
Quantitative variables were represented by measures of central 
tendency. First, the Kolmogorov test was performed to determine 
the normality of the variables. The one-way ANOVA test was 
used to contrast the cytokines levels per BMI classification of the 
patients and independent sample Student’s t-tests or the Mann 
Whitney U tests were used to do multiple comparisons between 
groups for all BMI classes. The critical p-values for the t-tests and 
Mann Whitney U tests were adjusted using a Bonferroni correction 
to control for the increased risk of Type I error associated with 
multiple comparisons. Based on the Gaussian distribution of the 
variables, either Pearson or Spearmen correlation were used 
among the cytokines and anthropometric variables as well as 
between BMI difference and the cytokines and between the IL-4/
TNF-α ratio and the BMI. Also, multiple regression was done for 
each cytokine, introducing age, BMI and blood pressure levels 
as independent variables. In all cases p ≤ .05 was considered 
statistically significant. The statistical analyses were carried out 
using SPSS, version 19.
 
Ethical statements
This project was approved by the Ethics and Research Committee 
of the HMPMPS (code: 2015-09-415). Negligible risk from this 
study was attributed to pregnant women or their neonates 
according to the regulations of the General Law on Health in 
Research Matters, and our study complied with standards of 
the Declaration of Helsinki (Fortaleza, Brazil). This project was 
assigned ClinicalTrials.gov ID: NCT03761966.
Results
During the year 2017, 83 women were enrolled in the study. The 
general characteristics of included patients are depicted in Table 
1. After performing the Kolmogorov test the only two variables 
that showed a non-parametric distribution were IFN-γ and IL-10.
The BMI distribution of the patients at the first prenatal 
medical visit was as follows: Underweight 3, Normal weight 27, 
Overweight 30, Obesity Class I 17, Obesity Class II 5, and Obesity 
Class III 1. When contrasting the cytokines values according to 
BMI classification IL-4 was significantly higher in Underweight 
compared Overweight patients (97.5 ± 3.5 vs. 66.4 ± 17.6 pg/
mL, p = .037), Underweight comparted to the Obesity Class 
I patients (97.5 ± 3.5 vs. 60.6 ± 17.2 pg/mL, p = .024) and 
Normal Weight compared to the Obesity Class I patients (72.2 ± 
17.7 vs. 60.6 ± 17.2 pg/mL, p = .026). TNF-α was significantly 
higher in Normal Weight than Obesity Class II patients (41.9 ± 
26 vs. 24.9 ± 19.7 pg/mL, p = .031) (Table 2, Figure 1).
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Table 1. General characteristics of the patients
 Variable Minimun Maximum Mean SD
Age (years) 18 43 28.5 7.1
Gestational age (weeks) 6 38 18 6
PG Weight (kg) 46.5 102 66.2 11.5
PG BMI (kg/m2) 18.6 40.7 27.5 4.3
Pregnancies (number) 1 7 2.7 1.5
Vaginal deliveries (number) 0 6 0.88 1.3
Abortions (number) 0 3 0.47 0.73
Cesareans (number) 0 3 0.47 0.71
Weight (kg) 42.7 102 66 11.9
BMI (kg/m2) 18.5 40.7 27.2 4.5
SBP (mmHg) 70 125 102.9 11.9
DBP (mmHg) 40 80 63.7 10.2
MAP (mmHg) 50 95 76.8 9.9
IL-4 (pg/mL) 32.5 121.7 67.5 20.2
IL-6 (pg/mL) 13.8 406.1 161.0 84.4
IL-10 (pg/mL) 2.1 244.8 51.9 43.7
IFN-γ (pg/mL) 0.04 94.2 5.9 11.1
TNF-α (pg/mL) 4.3 138.2 35.8 23.0
BMI: Body Mass Index, DBP: Diastolic Blood Pressure, IFN-γ: Interferon gamma, IL: Interleukin, MAP: Mean Arterial Pressure, PG: Pregestational, SBP: Systolic Blood Pressure, 
SD: Standard Deviation, TNF-α: Tumor Necrosis Factor alpha.
Table 2. Cytokines levels per BMI status














































































































IFN-γ: Interferon gamma, IL: Interleukin, TNF-α: Tumor Necrosis Factor alpha, a: statistical difference between Underweight and Overweight, b: statistical difference between 
Underweight and Obesity Grade I, c: statistical difference between Normal Weight and Obesity Grade I, d: statistical difference between Normal Weight and Obesity Grade II. 
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Figure 1. Serum levels of IL-4 and TNF-α per BMI classification. 
BMI: Body Mass Index, IL: interleukin, TNF-α: tumor necrosis factor alpha. Data are displayed as minimum, first quartile, median, third quartile, and maximum.
Table 3. Correlation matrix
Agea PG BMIa BMIa SBPa DBPa MAPa IL-4a IL-6a TNF-αa IL-10b IFN-γb
Age
Correlation 1 .005 -.018
p* .962 .875
PG BMI
Correlation .289 1 -.186 .046
p* .009 .094 .678
BMI
Correlation .303 .692 1 -.247 .081
S p* ig. .006 .000 .024 .468
SBP
Correlation .285 .184 .201 1 .142 -.018
p* .011 .107 .075 .212 .874
DBP
Correlation .135 .081 .109 .676 1 .144 -.225
p* .238 .478 .340 .000 .204 .047
MAP
Correlation .147 .084 .577 .863 .955 1 .110 -.138
p* .188 .454 .000 .000 .000 .322 .213
IL-4
Correlation .051 -.225 -.207 .169 .034 -.102 1 .356 -.246
p*Sig. .647 .042 .061 .137 .767 .358 .001 .025
IL-6
Correlation .163 .090 .028 .090 .110 -.087 .084 1 .031 -.232
p* .143 .422 .803 .430 .332 .434 .448 .782 .035
TNF-α
Correlation -.109 -.168 -.187 .219 .094 -.004 .244 .170 1 .005 -.018
p* .328 .132 .090 .052 .410 .970 .026 .125 .962 .875
*: Two sided significance, a: Pearson, b: Spearman, BMI: Body Mass Index, DBP: Diastolic Blood Pressure, IFN-γ: Interferon gamma, IL: Interleukin, MAP: Mean Arterial 
Pressure, PG: Pregestational, SBP: Systolic Blood Pressure, TNF-α: Tumor Necrosis Factor alpha.
From the physical exam parameters, the BMI was negatively 
correlated with IL-10 (r2 = -.247, p = .024), pre-gestational BMI 
with IL-4 (r2 = -.225, p = .042) and Diastolic Blood Pressure (DBP) 
with IFN-γ (r2 = -.225, p = .047) and the result between Systolic 
Blood Pressure and TNF-α was almost significant (r2 = .219, p = 
.052). Among the cytokines, IL-4 was positively correlated with 
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TNF-α (r2 = .244, p = .026) and IL-10 (r2 = .356, p = .001); by 
contrast, there was a negative correlation between IFN-γ and 
IL-4 (r2 = -.246, p = .025) and IL-6 (r2 = -.232, p = .035) (Table 
3). No linear relationship between the BMI difference with any 
of the cytokines was identified and it was also absent between 
the IL-4/TNF-α ratio and the baseline BMI.
Multiple regression analysis with the independent variables 
age, SBP, DBP, Pregestational BMI and BMI difference was 
performed for each cytokine and it only reached significance 
for TNF-α (r2 = .142, p = .049). For this model the Variance 
Inflation Factor (VIF) approached 1 with the four cytokines (Table 
4) indicating an acceptable degree of multicollinearity between 
the independent variables. 
Discussion




Model summary VIF ANOVA
Beta R R2 F p-value




PG BMI -.293 .014
BMI difference .090 .431




PG BMI .066 .588
BMI difference .183 .124




PG BMI -.197 .105
BMI difference -.098 .403




PG BMI .075 .525
BMI difference -.032 .781




PG BMI -.198 .092
BMI difference -.150 .187
BMI: Body Mass Index, BMI difference = BMI in the first medical consultation – Pregestational BMI, DBP: Diastolic Blood Pressure, IFN-γ: Interferon gamma, IL: Interleukin, 
MAP: Mean Arterial Pressure, PG: Pregestational, SBP: Systolic Blood Pressure, TNF-α: Tumor Necrosis Factor alpha, VIF: Variance Inflation Factor.
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In our study, the cytokines IL4-and IL-10 tended to diminish as 
the patient’s weight increased, and the behavior of TNF-α had 
the same trend. The response of the first two was unexpected, 
as in normal pregnancy Th2 cells are upregulated at the end of 
the first trimester16. 
Several authors have published that pregnancies in obese 
women have a dysregulated maternal cytokine profile with a 
significant rise in proinflammatory cytokines17,18. In contrast, in 
our study, a predominant Th1 profile not confirmed.
The findings with TNF are disconcerting because their 
concentrations fall with a higher BMI. TNF-α is probably the 
most studied cytokine regarding inflammation and obesity, 
including pregnancy and Gestational Diabetes Mellitus (GDM). 
However, the reported results are heterogeneous; while some 
groups have published increased circulating TNF-α in maternal 
serum correlating with an increasing BMI, several other studies 
do not report that correlation19-21. Increased circulating TNF-α 
may be related to the development of GDM, but a more extensive 
an excellent review of these discrepancies can be found with 
Pantham et al22. This leaves the IFN as the primary agent with 
proinflammatory signals in the initial phase of pregnancy. 
Generally speaking, although the correlation analyses 
produced statistically significant results, the strength of the 
associations was weak (r2<.3). Further work is required to 
understand in detail the negative correlations in pregnancy 
between BMI with IL-10, pre-gestational BMI with IL-4, and DBP 
with IFN-γ. A handful of factors may contribute to the marked 
disparities in correlations of cytokines with anthropometric 
variables, but some may be interpreted as prognostic biomarkers 
for obstetrical complications23-25. 
Concerning the interaction among the cytokines, the 
positive correlation between IL-4 and IL-10, and both showing 
decreasing values with increasing BMI reflects a tendency to a 
diminished Th2 profile (anti-inflammatory state) at the beginning 
of pregnancy.
Maintenance of immunological tolerance to fetal antigens is 
a critical process during pregnancy, which must be accomplished 
without a detrimental effect in the induction of an immune 
response to pathogens. The old paradigm that pregnancy is an 
anti-inflammatory state has been already disregarded as new 
evidence has shown that pregnancy has specific mechanisms 
of maintenance of tolerance to fetal antigens, and a particular 
subset of natural killer (NK) lymphocyte cells, termed uterine NK 
cells, are central to this phenomenon, along with many other 
classical tolerance mechanisms26. 
Obese women offspring have a higher risk of developing 
chronic diseases associated with an altered immune function, 
characterized by a macrophages M1 (LPS/IFNγ) induction 
and more than 60% of Mexican women, are unhealthy when 
becoming pregnant with a BMI ≥ 30, in contrast to other 
countries e.g. Mongolia in which this percentage is 10%27,28. 
The functioning of the cytokine network, providing the 
relationships and interactions between the decidual and 
trophoblast cells, is one of the mechanisms responsible for 
the maternal immune system tolerance of the fetal antigens of 
paternal origin. Th1 cytokines are the key mediators of immune 
reactions associated with graft rejection, while Th2 cytokines 
mediate the immunological tolerance induction29. It has been 
shown that healthy pregnancy is associated with predominantly 
Th2 immunological reactions with secretion of the appropriate 
spectrum of anti-inflammatory cytokines. The development of 
complications, for example, early embryonic loss, is attributed to 
the Th1 response and the respective cytokine profile30. 
Low levels of anti-inflammatory cytokines during the 
early periods of gestation are characteristic of patients with a 
history of habitual miscarriages; however, an anti-inflammatory 
shift of the cytokine spectrum develops by the end of the first 
trimester31. A previous work demonstrated that the fetuses of 
class II–III obese women are exposed in utero to higher cytokine 
and Matrix metalloproteinases (MMP) levels than fetuses of lean 
women32. The long-term effect of each proinflammatory cytokine 
on the fetal prognosis is still under scrutiny33.
Previous authors have postulated that circulating immune 
markers may be associated with preeclampsia. In this line, a 
study with Taiwanese women did not support a role of the IL-4 
gene in the pathogenesis of preeclampsia34. On the contrary, 
successful pregnancy in humans has been associated with 
efficient production of IL-435. On the other hand, IL-10 is induced 
in inflammatory conditions to counteract proinflammatory 
cytokines, thereby considered as an important homeostatic 
mechanism to avoid inappropriate T cell activation36. In the 
context of pregnancy, IL-10 is broadly express and shows 
pleiotropic effects37.
Research concerning IFN-γ has established that IL-12 
production by macrophages is known to induce its production 
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by CD4+ T cells38. Contrasting this information with our results, 
IFN-γ was confirmed as a critical proinflammatory cytokine, is in 
fact the most important in the first medical consultation.
In conclusion, in Mexican women, there is a low anti-
inflammatory cytokine profile at the beginning of pregnancy, 
adding to the risk factors of obstetrical complications within this 
population39,40.
Together, this information leads to the possibility of 
designing a Pregestational Healthy Index (PGHI). In an initial 
attempt, the construction of this PGHI should take into account 
not only the BMI but also the pre-gestational levels of IL-4, IL-
10, IFN-γ, leptin and qualitative variables such as a family history 
of preeclampsia/eclampsia and gestational diabetes mellitus.
Interestingly, Retnakaran et al. have published a paper 
concerning the maternal pre-gravid cardiometabolic health 
and infant birth weight41. They concluded that maternal weight 
before and during pregnancy is the predominant cardiometabolic 
determinant of infant birth weight, excluding pre-gravid blood 
pressure, glucose, and lipid profile. 
Our paper has some limitations. The pregestational BMI was 
calculated based on the pre-gestational weight that the patient 
remembered as closest before she knew she was pregnant, 
which undoubtedly brings several biases. Other variables that 
may have an influence on cytokine levels were not studied. 
Notwithstanding, there is enough information to recognize the 
challenge that doctors face managing a pregnancy to fruition if 
patients begin their pregnancy obese and a proper regulation in 
IL-4 and IL-10 are conducive to that objective.
Finally, it is important to mention that although several 
studies are underway to evaluate molecules that inhibit the 
proinflammatory signals of TNF-α and interferon42. However, it 
is unlikely that TNF-α and interferon would approved for studies 
on pregnant women due to the teratogenic risks and even less 
so because it is already known that a balanced diet is a key to 
have a pregnancy with minimal risks.
Based on the above, everything indicates that our objective 
should be to design strategies help Mexican women have the 
best health before pregnancy, that because of economic and 
cultural conditions it is currently a great challenge to maintain a 
healthy weight after becoming pregnant.
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